Impact of Public-Private Partnerships Addressing Access to Pharmaceuticals in Low Income Countries: Uganda Pilot Study
Loading...
Date
2003
Journal Title
Journal ISSN
Volume Title
Publisher
Initiative on Public-Private Partnerships for Health, Global Forum for Health Research
Abstract
In a vicious cycle, poverty is a major cause of health inequity in developing countries, and ill-health perpetuates poverty. Many health problems among populations disadvantaged by poverty have been neglected because of lack of commercial incentives or have proven intractable when tackled by the public sector or NGOs independently. In recent years, a number of public-private partnerships (PPPs), usually targeted on specific products, diseases or technologies, have arisen to tackle particular health problems. One group of PPPs addresses access to pharmaceuticals critical to treatment or care for diseases disproportionately or uniquely affecting the poor in developing countries. This category of partnerships for drug access is usually based around the
provision of products that are donated or heavily discounted (usually a ‘sole source’). They entail a multi partner effort at field level to ensure the distribution and proper use of the medications.
Description
Keywords
HIV/AIDS, Poverty Reduction Strategies, Public-Private Partnerships
Citation
Caines, K., Bataringaya, J., Lush, L., Murindwa, G., & N’jie, H. (2003). Impact of Public-Private Partnerships Addressing Access to Pharmaceuticals in Low Income Countries: Uganda Pilot Study. Geneva: Initiative on Public-Private Partnerships for Health.